Etiological involvement of CFTR in apparently unrelated human diseases

Lorenzo Galluzzi; Guido Kroemer

doi:10.1080/23723556.2018.1558874

Etiological involvement of CFTR in apparently unrelated human diseases

Lorenzo Galluzzi, Guido Kroemer

Résultats de recherche: Contribution à un journal › !!Comment/debate

3 Citations (Scopus)

langue originale	Anglais
Numéro d'article	1558874
journal	Molecular and Cellular Oncology
Volume	6
Numéro de publication	1
Les DOIs	https://doi.org/10.1080/23723556.2018.1558874
état	Publié - 2 janv. 2019

Accès au document

10.1080/23723556.2018.1558874

Autres fichiers et liens

Lien vers la publication dans Scopus

Contient cette citation

@article{8ad41a8be93b4fab97067b0ae29895ef,

title = "Etiological involvement of CFTR in apparently unrelated human diseases",

keywords = "Sj{\"o}gren{\textquoteright} syndrome, autophagy, cancer, celiac disease, chronic pancreatitis, cystic fibrosis",

author = "Lorenzo Galluzzi and Guido Kroemer",

note = "Funding Information: LG is supported by a Breakthrough Level 2 grant from the US Department of Defense (DoD), Breast Cancer Research Program (BRCP) [#BC180476P1], by a startup grant from the Department of Radiation Oncology at Weill Cornell Medicine (New York, USA), by industrial collaborations with Lytix (Oslo, Norway) and Phosplatin (New York, US), and by donations from Phosplatin (New York, US), the Luke Heller TECPR2 Foundation (Boston, US) and Sotio a.s. (Prague, Czech Republic). GK is supported by the Ligue contre le Cancer ({\'e}quipe labellis{\'e}e); Agence National de la Recherche (ANR) – Projets blancs; ANR under the frame of E-Rare-2, the ERA-Net for Research on Rare Diseases; Association pour la recherche sur le cancer (ARC); Canc{\'e}rop{\^o}le Ile-de-France; Chancelerie des universit{\'e}s de Paris (Legs Poix), Fondation pour la Recherche M{\'e}dicale (FRM); a donation by Elior; the European Commission (ArtForce); European Research Area Network on Cardiovascular Diseases (ERA-CVD, MINOTAUR); the European Research Council (ERC); Fondation Carrefour; Institut National du Cancer (INCa); Inserm (HTE); Institut Universitaire de France; LeDucq Foundation; the LabEx Immuno-Oncology; the RHU Torino Lumi{\`e}re; the Seerave Foundation; the SIRIC Stratified Oncology Cell DNA Repair and Tumor Immune Elimination (SOCRATE); and the SIRIC Cancer Research and Personalized Medicine (CARPEM).",

year = "2019",

month = jan,

day = "2",

doi = "10.1080/23723556.2018.1558874",

language = "English",

volume = "6",

journal = "Molecular and Cellular Oncology",

issn = "2372-3556",

number = "1",

}

TY - JOUR

T1 - Etiological involvement of CFTR in apparently unrelated human diseases

AU - Galluzzi, Lorenzo

AU - Kroemer, Guido

N1 - Funding Information: LG is supported by a Breakthrough Level 2 grant from the US Department of Defense (DoD), Breast Cancer Research Program (BRCP) [#BC180476P1], by a startup grant from the Department of Radiation Oncology at Weill Cornell Medicine (New York, USA), by industrial collaborations with Lytix (Oslo, Norway) and Phosplatin (New York, US), and by donations from Phosplatin (New York, US), the Luke Heller TECPR2 Foundation (Boston, US) and Sotio a.s. (Prague, Czech Republic). GK is supported by the Ligue contre le Cancer (équipe labellisée); Agence National de la Recherche (ANR) – Projets blancs; ANR under the frame of E-Rare-2, the ERA-Net for Research on Rare Diseases; Association pour la recherche sur le cancer (ARC); Cancéropôle Ile-de-France; Chancelerie des universités de Paris (Legs Poix), Fondation pour la Recherche Médicale (FRM); a donation by Elior; the European Commission (ArtForce); European Research Area Network on Cardiovascular Diseases (ERA-CVD, MINOTAUR); the European Research Council (ERC); Fondation Carrefour; Institut National du Cancer (INCa); Inserm (HTE); Institut Universitaire de France; LeDucq Foundation; the LabEx Immuno-Oncology; the RHU Torino Lumière; the Seerave Foundation; the SIRIC Stratified Oncology Cell DNA Repair and Tumor Immune Elimination (SOCRATE); and the SIRIC Cancer Research and Personalized Medicine (CARPEM).

PY - 2019/1/2

Y1 - 2019/1/2

KW - Sjögren’ syndrome

KW - autophagy

KW - cancer

KW - celiac disease

KW - chronic pancreatitis

KW - cystic fibrosis

UR - http://www.scopus.com/inward/record.url?scp=85059310520&partnerID=8YFLogxK

U2 - 10.1080/23723556.2018.1558874

DO - 10.1080/23723556.2018.1558874

M3 - Comment/debate

AN - SCOPUS:85059310520

SN - 2372-3556

VL - 6

JO - Molecular and Cellular Oncology

JF - Molecular and Cellular Oncology

IS - 1

M1 - 1558874

ER -